Cancer Family
Thoracic Neoplasm
CI-CAN-00000054Explore in graph →
Non-malignant2,893 active trials51 approved drugs626 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000054Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00568841 | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)(ERLOPET) | unknown | Phase 2 | 40 | Lung Cancer Group CologneOTHER | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00964132 | Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 48 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 3, 2009 |
| NCT00801385 | Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | unknown | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00786331 | Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC | unknown | Phase 2 | 230 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 43 | National University Hospital, SingaporeOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00935571 | Incidence of Postthoracotomy Pain Following General Anesthesia: A Comparison Between TIVA and Inhalation Anesthesia | unknown | — | 400 | Asan Medical CenterOTHER | 1 | Jul 9, 2009 | clinicaltrials |
| NCT00300729 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy(CYCLUS) | unknown | Phase 3 | 319 | University Hospital, LinkoepingOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00923637 | Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer | unknown | Phase 2 | 75 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2009 | clinicaltrials |
| NCT00908336 | Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen | unknown | Phase 2 | 70 | Hospital Arnau de VilanovaOTHER | 1 | May 25, 2009 | clinicaltrials |
| NCT00905983 | Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 48 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00906061 | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 76 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00173524 | PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00903292 | Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma | unknown | N/A | 52 | National Cheng-Kung University HospitalOTHER | 1 | May 18, 2009 | clinicaltrials |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | unknown | Phase 2 | 31 | National Institute of CancerologíaOTHER_GOV | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| NCT00880945 | Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions | unknown | — | 40 | Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00006347 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00006458 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00675168 | Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice(PROLOG) | unknown | Phase 4 | 1,700 | Odense University HospitalOTHER | 1 | Feb 19, 2009 | clinicaltrials |
| NCT00845143 | Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer | unknown | — | 100 | Heidelberg UniversityOTHER | 0 | Feb 18, 2009 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | unknown | Phase 3 | 280 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00006087 | Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer | unknown | N/A | — | Jewish Hospital and St. Mary's HealthcareOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00077220 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00274898 | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | unknown | Phase 2 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616499 | Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | unknown | Phase 2 | 35 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | unknown | Phase 2 | 41 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00828022 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer(SMC4692) | unknown | Phase 1 / Phase 2 | 15 | Soroka University Medical CenterOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00815971 | Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib | unknown | — | 300 | Aarhus University HospitalOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00497250 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | unknown | Phase 1 | 32 | Fudan UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00631839 | Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury | unknown | — | 140 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Oct 7, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00727350 | Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. | unknown | Phase 2 | 44 | Universitair Ziekenhuis BrusselOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00006116 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00014547 | BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075517 | Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00184964 | Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis | unknown | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00690261 | The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00687778 | 11C-Acetate PET/CT Non-FDG-Avid Tumors | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00273494 | Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 | unknown | Phase 3 | 406 | Rigshospitalet, DenmarkOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00678964 | Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(TIE) | unknown | Phase 2 | 260 | LungenClinic GrosshansdorfOTHER | 1 | May 16, 2008 | clinicaltrials |
| NCT00673777 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00674258 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 14, 2008 | clinicaltrials |
| NCT00663689 | Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer | unknown | Phase 2 | 45 | Guangdong Provincial People's HospitalOTHER | 0 | Apr 22, 2008 | clinicaltrials |
| NCT00379717 | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 13, 2008 | clinicaltrials |
| NCT00319800 | Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00502762 | Topotecan for Irinotecan-Refractory SCLC | unknown | Phase 2 | — | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00625352 | Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma | unknown | Phase 2 | 48 | Ulsan University HospitalOTHER | 1 | Feb 28, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2009source: clinicaltrials